上海合晶硅材料股份有限公司 募集资金存放与使用情况鉴证报告 2024 年度 您可使用手机"扫一扫"或进入"注册会计师行业绩"是否用具有执业许可的会计师事务 所出具 "进行查盟 户5NV . 关于上海合晶硅材料股份有限公司 2024 年度募集资金存放与使用情况专项报告的 鉴证报告 信会师报字[2025]第ZA10191号 上海合晶硅材料股份有限公司全体股东: 我们接受委托,对后附的上海合晶硅材料股份有限公司(以下简 称"上海合晶")2024 年度募集资金存放与使用情况专项报告(以下 简称"募集资金专项报告")执行了合理保证的鉴证业务。 一、董事会的责任 上海合晶董事会的责任是按照中国证券监督管理委员会《上市公 司监管指引第 2 号 -- 上市公司募集资金管理和使用的监管要求 (2022 年修订 )》(证监会公告〔2022〕15 号)、《上海证券交易所科 创板上市公司自律监管指引第1号 -- 规范运作》以及《上海证券交 易所上市公司自律监管指南第 1 号 - 集资金专项报告。这种责任包括设计、执行和维护与募集资金专项报 告编制相关的内部控制,确保募集资金专项报告真实、准确、完整, 不存在虚假记载、误导性陈述或重大 ...

证券代码：688584 证券简称：上海合晶 公告编号：2025-008 上海合晶硅材料股份有限公司 关于对外投资设立合资公司暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次与关联方共同对外投资设立合资公司暨关联交易事项已经公司第二届董 事会第十八次会议审议通过。同时已经独立董事专门会议审议并取得明确同意的意见， 公司保荐人中信证券股份有限公司（以下简称"保荐人"）对该事项出具了明确的核 查意见。此项交易无需提交股东大会审议。 相关风险提示： 关联交易简要内容：上海合晶硅材料股份有限公司（以下简称"公司"或"上海 合晶"）拟与Wafer Works Investment Corp.（以下简称"WWIC"）共同出资设立合资公司。 合资公司注册资本拟不超过5,000万元人民币。其中，上海合晶拟出资不超过 2,000万元 人民币，占合资公司注册资本的40%。 本次关联交易实施不存在重大法律障碍。 （1）合资公司的设立尚需工商行政管理部门等相关主管部门的批准，能否通过相 关批准以及最终通过批准的 ...

一、计提资产减值准备情况 证券代码：688584 证券简称：上海合晶 公告编号：2025-016 上海合晶硅材料股份有限公司 关于2024年度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 二、2024 年度计提资产减值准备事项的具体说明 （一）信用减值损失 公司考虑合理且有依据的信息，包括前瞻性信息，以单项或组合的方式对 应收票据、应收账款及其他应收款等的预期信用损失进行测试和估计。经测试， 2024年度需计提信用减值损失金额 10.52 万元。 （二）资产减值损失 公司对存货采用成本与可变现净值孰低方法进行减值测试，资产负债表日 公司综合评估存货可变现净值，对成本高于可变现净值的存货计提存货跌价准 备。经测试，2024 年度需计提资产减值损失金额共计 1,415.90 万元。 三、本次计提资产减值准备对公司的影响 2024 年公司计提信用减值损失和资产减值损失共计人民币 1,426.42 万元， 占公司 2024 年合并归母净利润的 11.81%。本次计提资产减值准备事项已经审 计，相关金额与 ...

证券代码：688584 证券简称：上海合晶 公告编号：2025-005 上海合晶硅材料股份有限公司 第二届监事会第十七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 上海合晶硅材料股份有限公司（以下简称"公司"）第二届监事会第十七次 会议（以下简称"本次会议"）于 2025 年 3 月 18 日以现场与通讯相结合的方式 召开，本次会议通知已于 2025 年 3 月 8 日以邮件方式送达公司全体监事。本次 会议由监事会主席叶德昌先生主持，应出席会议的监事 3 名，实际出席会议的监 事 3 名。本次会议的召集、召开符合《中华人民共和国公司法》等法律、法规、 规范性文件和《上海合晶硅材料股份有限公司章程》的有关规定。 二、监事会会议审议情况 （一） 审议并通过《关于 2024 年年度报告及其摘要的议案》 经审核，监事会认为：董事会编制和审议 2024 年年度报告的程序符合法律、 行政法规规定，公司 2024 年年度报告及摘要内容真实、准确、完整地反映了公 司 2024 年度的经营实际情况， ...

证券代码：688584 证券简称：上海合晶 公告编号：2025-004 上海合晶硅材料股份有限公司 第二届董事会第十八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 上海合晶硅材料股份有限公司（以下简称"公司"）第二届董事会第十八次 会议（以下简称"本次会议"）于 2025 年 3 月 18 日以现场与通讯相结合的方式 召开，本次会议通知已于 2024 年 3 月 8 日以邮件方式送达公司全体董事。本次 会议由董事长刘苏生先生主持，应出席会议的董事 9 名，实际出席会议的董事 9 名。本次会议的召集、召开符合《中华人民共和国公司法》等法律、法规、规范 性文件和《上海合晶硅材料股份有限公司章程》（以下简称"《公司章程》"）的有 关规定。 二、董事会会议审议情况 （一） 审议并通过《关于 2024 年年度报告及其摘要的议案》 本议案已经公司第二届董事会审计委员会审议通过，尚需提交公司股东大会 审议。 表决结果：9 票同意，0 票反对，0 票弃权。 详见同日在上海证券交易所（http:// ...

Financial Performance - The company's operating revenue for 2024 was CNY 110,873.63 million, a decrease of 17.76% compared to CNY 134,817.37 million in 2023[21]. - The net profit attributable to shareholders for 2024 was CNY 12,078.34 million, down 51.07% from CNY 24,686.10 million in 2023[21]. - The net profit after deducting non-recurring gains and losses for 2024 was CNY 10,751.57 million, a decline of 49.58% from CNY 21,322.79 million in 2023[21]. - The net cash flow from operating activities for 2024 was CNY 44,823.20 million, a decrease of 22.50% compared to CNY 57,836.63 million in 2023[21]. - The total assets at the end of 2024 were CNY 457,129.54 million, an increase of 24.44% from CNY 367,344.18 million at the end of 2023[21]. - The net assets attributable to shareholders at the end of 2024 were CNY 414,111.57 million, up 48.49% from CNY 278,881.78 million at the end of 2023[21]. - Basic earnings per share for 2024 were CNY 0.18, a decrease of 56.10% from CNY 0.41 in 2023[22]. - Diluted earnings per share for 2024 were also CNY 0.18, reflecting the same decline of 56.10% from CNY 0.41 in 2023[22]. Dividend Policy - The proposed cash dividend for 2024 is CNY 2.00 per 10 shares, totaling CNY 133,091,670.60, which represents 110.19% of the net profit attributable to shareholders[6]. - The cumulative cash dividend over the last three fiscal years amounts to CNY 133,091,700, with an average net profit of CNY 120,783,353.84, resulting in a cash dividend ratio of 110.19%[171]. - The company has a clear cash dividend policy that protects the rights of minority shareholders, with no adjustments made during the reporting period[167]. Research and Development - Research and development expenses accounted for 9.01% of operating revenue, an increase of 0.36 percentage points compared to the previous year[31]. - The company invested 99.93 million yuan in 30 R&D projects during the reporting period, with 17 projects completed and entering mass production or operation[35]. - The company applied for 61 patents during the reporting period, including 13 invention patents and 48 utility model patents, and currently holds 30 domestic and international invention patents[36]. - The total R&D investment amounted to 9,992.77 million yuan, a decrease of 14.33% compared to the previous year, with R&D investment accounting for 9.01% of operating income, an increase of 0.36 percentage points[64]. Market Position and Strategy - The company is one of the few integrated manufacturers of semiconductor silicon epitaxial wafers in China, supplying to 7 of the top 10 global wafer foundries and 6 of the top 10 power device IDM manufacturers[55]. - The company is actively expanding its production capacity for 12-inch large-size silicon wafers and aims to promote high-end domestic substitution in the power device sector[31]. - The company aims to establish its 8-inch epitaxial wafers as a benchmark and rapidly strengthen its 12-inch segment by implementing cost reduction and efficiency enhancement measures[31]. - The company is committed to advancing its research and development in semiconductor materials to meet the diverse application needs of emerging fields such as IoT and renewable energy[57]. Risks and Challenges - The company has not reported any significant risks that could materially affect its operations during the reporting period[4]. - The company faces risks related to a significant reliance on 8-inch epitaxial wafer products, with potential impacts on future growth if it fails to scale up 12-inch production[80]. - The company is exposed to risks from raw material price fluctuations and supply chain stability, which could adversely affect operational performance[80]. - The semiconductor market's downturn has led to reduced demand and increased competition, impacting the company's performance[92]. Environmental and Compliance - The company invested 2,011.38 million CNY in environmental protection during the reporting period[191]. - The company has implemented strict adherence to national environmental laws and local regulations, ensuring all emissions are regularly tested and reported[197]. - The company maintained compliance with environmental regulations across all facilities, with regular monitoring and testing of emissions[197]. - The company has implemented multiple treatment processes for wastewater, including regulation, reaction, coagulation, and sedimentation pools, achieving effective separation of clean and polluted water[200]. Corporate Governance and Leadership - The company experienced a significant turnover in its board, with Yu Jingwei and He Lin resigning from their positions in August 2024 for personal reasons[138]. - The company has implemented a stock option incentive plan, with various board members participating and receiving substantial remuneration[137]. - The total remuneration for all directors, supervisors, and senior management personnel at the end of the reporting period amounted to 5.1947 million RMB[147]. - The company is actively managing its leadership structure, with several changes in key positions to align with strategic goals[138]. Future Outlook - The company provided an optimistic outlook for the next quarter, projecting revenue growth of 25% and aiming for $1.875 billion[139]. - The company plans to expand production capacity for 12-inch silicon epitaxy and improve technology in crystal growth, substrate formation, and epitaxy growth processes[121]. - The company is exploring partnerships with leading tech firms to co-develop innovative semiconductor solutions, aiming to enhance its competitive edge[141]. - Future guidance includes maintaining a net profit margin of at least 10% for the upcoming fiscal year[140].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 每股分配比例：每 10 股派发现金红利 2.00 元（含税），不送红股，不进 行资本公积转增股本。 证券代码：688584 证券简称：上海合晶 公告编号：2025-006 上海合晶硅材料股份有限公司 关于2024年度利润分配方案的公告 重要内容提示： 本次利润分配以实施权益分派股权登记日登记的总股本为基数，具体日期 将在权益分派实施公告中明确。 在实施权益分派的股权登记日前公司总股本发生变动的，拟维持分配总额 不变，相应调整每股分配比例，并将另行公告具体调整情况。 公司未触及《上海证券交易所科创板股票上市规则》第 12.9.1 条第一款第 （八）项规定的可能被实施其他风险警示的情形。 一、利润分配方案的内容 经立信会计师事务所（特殊普通合伙）审计确认，2024 年上海合晶硅材料股 份有限公司（以下简称"公司"）母公司实现税后净利润 217,480,627.90 元，提取 10%的 法 定 盈 余 公 积 金 21,748,062.79 元 ， 加 上 年 初 母 公 司 未 ...

Financial Performance - In 2024, the total operating revenue was CNY 110,873.63 million, a decrease of 17.76% compared to the previous year[4]. - The net profit attributable to shareholders of the parent company was CNY 12,078.34 million, down 51.07% year-on-year[4]. - The net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses was CNY 10,751.57 million, a decline of 49.58% compared to the previous year[4]. - The basic earnings per share decreased to CNY 0.18, down 56.10% from CNY 0.41 in the previous year[4]. - The decline in revenue and profit was primarily due to the cyclical downturn in the semiconductor industry, leading to reduced order volumes and lower selling prices[6]. - The weighted average return on net assets decreased to 3.07%, down 6.13 percentage points from the previous year[4]. Assets and Equity - The total assets at the end of 2024 were CNY 457,129.54 million, an increase of 24.44% year-on-year[6]. - The equity attributable to shareholders of the parent company increased to CNY 414,111.57 million, up 48.49% compared to the previous year[6]. - The net asset per share attributable to shareholders of the parent company was CNY 6.22, reflecting a growth of 32.91% year-on-year[6]. Capital Raising - The company successfully raised capital through its listing, contributing to the increase in equity attributable to shareholders[7].